Clincosm LogoSign in Get a demo

multiple myeloma

Showing NaN - NaN of 228
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Multiple Myeloma, Relapse Multiple Myeloma, Multiple Myeloma Trial in Boston (Elranatamab)

Not yet recruiting
  • Refractory Multiple Myeloma
  • +2 more
  • Boston, Massachusetts
  • +2 more
Nov 17, 2023

Multiple Myeloma Trial in Boston (BMS-986393, Alnuctamab, Mezigdomide)

Not yet recruiting
  • Multiple Myeloma
  • Boston, Massachusetts
  • +1 more
Nov 2, 2023

Multiple Myeloma Trial in Boston (THRIVE-M)

Not yet recruiting
  • Multiple Myeloma
  • THRIVE-M
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 2, 2023

Multiple Myeloma Trial in Worldwide (idecabtagene vicleucel, Lenalidomide, Fludarabine)

Not yet recruiting
  • Multiple Myeloma
  • idecabtagene vicleucel
  • +3 more
  • Gilbert, Arizona
  • +107 more
Sep 26, 2023

Relapsed Cancer, Refractory Multiple Myeloma, Multiple Myeloma Trial in Boston (Isatuximab, Belantamab mafodotin, Pomalidomide)

Not yet recruiting
  • Relapsed Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jun 19, 2023

Biomarker for Infection Risk in CLL and MM

Not yet recruiting
  • Multiple Myeloma
  • Chronic Lymphocytic Leukemia
  • Screening
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
May 3, 2023

Multiple Myeloma, Smoldering Multiple Myeloma Trial in Boston (Ciltacabtagene Autoleucel, Cyclophosphamide, Fludarabine

Not yet recruiting
  • Multiple Myeloma
  • Smoldering Multiple Myeloma
  • Ciltacabtagene Autoleucel
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 2, 2023

Multiple Myeloma, Stem Cell Transplant Complications Trial in Boston (PARE, Waitlist Control Group)

Not yet recruiting
  • Multiple Myeloma
  • Stem Cell Transplant Complications
  • PARE
  • Waitlist Control Group
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 30, 2023

Samples and Clinical Data From Patients With Amyloid Diseases

Recruiting
  • Multiple Myeloma
  • clonality analysis
  • +6 more
  • Boston, Massachusetts
    Boston University Cancer Research Center
Jan 28, 2023

Multiple Myeloma Trial in Worldwide (Bortezomib, Dexamethasone, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • San Francisco, California
  • +152 more
Jan 27, 2023

Multiple Myeloma Trial in Worldwide (Teclistamab, Daratumumab, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +189 more
Jan 27, 2023

Multiple Myeloma Trial in Spain, United States (BB2121, CC-220, BMS-986405)

Recruiting
  • Multiple Myeloma
  • BB2121
  • +2 more
  • Birmingham, Alabama
  • +33 more
Jan 26, 2023

Multiple Myeloma Trial in Boston, Columbus (drug, biological, other)

Terminated
  • Multiple Myeloma
  • Boston, Massachusetts
  • +1 more
Nov 14, 2022

Multiple Myeloma Trial in United States (Lenalidomide, Daratumumab/rHuPH20)

Recruiting
  • Multiple Myeloma
  • Anchorage, Alaska
  • +698 more
Jan 24, 2023

Hematologic Malignancy, Blood Cancer, Lymphoma Trial in Boston (Palliative Care, Usual Care)

Recruiting
  • Hematologic Malignancy
  • +4 more
  • Palliative Care
  • Usual Care
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jan 24, 2023

Multiple Myeloma Trial in Boston (Health Through Activity)

Not yet recruiting
  • Multiple Myeloma
  • Health Through Activity
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (Selinexor, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Birmingham, Alabama
  • +60 more
Jan 24, 2023

Multiple Myeloma Trial in Worldwide (Modakafusp Alfa, Daratumumab)

Recruiting
  • Multiple Myeloma
  • Gilbert, Arizona
  • +40 more
Jan 23, 2023

Multiple Myeloma Trial in Worldwide (Cevostamab, Tocilizumab)

Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +17 more
Jan 23, 2023

Multiple Myeloma Trial in Worldwide (Daratumumab, Lenalidomide, Dexamethasone)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Little Rock, Arkansas
  • +145 more
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (Daratumumab, Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +198 more
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (Daratumumab IV, Lenalidomide, Dexamethasone)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Daratumumab IV
  • +3 more
  • Birmingham, Alabama
  • +211 more
Jan 17, 2023

Multiple Myeloma Trial in France, Spain, United States (Daratumumab, Velcade, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Duarte, California
  • +21 more
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (Dara SC, Dara IV)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Dara SC
  • Dara IV
  • Boston, Massachusetts
  • +145 more
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (Daratumumab, Bortezomib, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Whittier, California
  • +113 more
Jan 17, 2023